pyridostigmine bromide has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferlin, EL; Harthmann, AD; Moraes, RS; Souza, WI | 1 |
Bharucha, AE; Burton, D; Camilleri, M; Gehrking, T; Kudva, Y; Low, P; Shah, P; Veil, E; Zinsmeister, AR | 1 |
Bresciani, E; Girelli, A; Giustina, A; Tassi, C; Valentini, U | 1 |
3 trial(s) available for pyridostigmine bromide and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Effect of peripheral cholinergic stimulation on autonomic modulation in Type 2 diabetes with autonomic neuropathy: a randomized controlled trial.
Topics: Analysis of Variance; Autonomic Nervous System Diseases; Cholinesterase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Humans; Pyridostigmine Bromide | 2014 |
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Algorithms; Cholinesterase Inhibitors; Constipation; Defecation; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Middle Aged; Pyridostigmine Bromide; Treatment Outcome | 2013 |
Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Synergism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Male; Middle Aged; Obesity; Pyridostigmine Bromide; Reference Values | 1994 |